Terms: = Liver cancer AND CgA AND Clinical Outcome
1 results:
1. Circulating Chromogranin A as A Marker for Monitoring clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Tian T; Gao J; Li N; Li Y; Lu M; Li Z; Lu Z; Li J; Shen L
PLoS One; 2016; 11(5):e0154679. PubMed ID: 27159453
[TBL] [Abstract] [Full Text] [Related]
